An Adalimumab-Induced Mucosal Red Storm in a Patient with Crohn’s Disease
Sign Up to like & getrecommendations! Published in 2022 at "Digestive Diseases and Sciences"
DOI: 10.1007/s10620-021-07351-1
Abstract: A 33-year-old female with a history of penetrating ileal Crohn’s disease (CD) complicated by ileal stricture and ileo-sigmoid fistula status post-ileocolic resection and segmental colectomy 10 years prior was seen for a complaint of abdominal… read more here.
Keywords: crohn disease; adalimumab induced; patient; induced mucosal ... See more keywords
Clip stopper closure method using a detachable snare in combination with ZEOCLIP for endoscopic submucosal dissection‐induced mucosal defects
Sign Up to like & getrecommendations! Published in 2022 at "Digestive Endoscopy"
DOI: 10.1111/den.14417
Abstract: Endoscopic submucosal dissection (ESD) is globally performed to treat early epithelial tumors of the gastrointestinal tract, but delayed perforation is a problematic procedure‐related complication. To address this problem, closure of ESD‐induced mucosal defects with a… read more here.
Keywords: induced mucosal; detachable snare; method using; closure ... See more keywords
Association of TRAP1 with infliximab‐induced mucosal healing in Crohn's disease
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Gastroenterology and Hepatology"
DOI: 10.1111/jgh.14696
Abstract: Anti‐tumor necrosis factor (TNF) agents, such as infliximab (IFX), have been increasingly used to induce and maintain disease remission in patients with Crohn's disease (CD). Despite a considerable non‐response rate, little is known about the… read more here.
Keywords: association trap1; trap1 infliximab; disease; induced mucosal ... See more keywords